Noteless, the Oslo-based AI firm innovating how docs doc affected person consultations, has efficiently raised €3.5 million in new Seed funding so as to develop its AI-powered scientific documentation platform to extra European markets and help wider adoption amongst clinicians.
The spherical was led by Redstone becoming a member of as a brand new investor, alongside Futurum Ventures and Farvatn Enterprise, who proceed their help.
“We’ve seen unbelievable adoption within the Nordics, the place a couple of in 4 common practitioners now use Noteless in Norway, and one in seven in Denmark” mentioned William Vossgård, CEO and co-founder of Noteless. “Clinicians inform us we’re giving them again as much as two hours a day, time they’ll spend with sufferers or on their very own wellbeing. This funding will assist us deliver that impression to clinicians throughout Europe.”
Different related corporations to Noteless have additionally raised funding this yr, offering a snapshot to the circulation of funding and concepts throughout the continent.
For instance, Berlin-based Aiomics secured €2 million in pre-Seed funding to develop its AI-driven healthcare documentation platform throughout various care settings. In the meantime, Stockholm-based Tandem Health raised a substantially larger €42.6 million Series A to scale its real-time medical notes assistant and prolong its attain throughout a number of European markets.
Taken collectively, these rounds – round €48 million throughout three corporations in 2025 – replicate a transparent development: traders are backing startups that purpose to scale back administrative overhead in healthcare through the use of AI for scientific documentation and workflow automation.
Noteless’s Seed spherical places it in a aggressive early-stage group alongside Aiomics, whereas Tandem’s a lot bigger Collection A suggests the market sees sturdy potential for scaling such options throughout Europe.
Based in 2023, Noteless is an AI-powered scientific documentation software that robotically generates medical notes whereas docs and sufferers discuss. By utilizing speech recognition and pure language processing, Noteless appears to be like to assist clinicians save time, cut back burnout, and enhance affected person care.
Noteless launched its first product in June 2024. The group has since grown to 35 workers throughout Norway, Denmark, and the Netherlands, processing over 3 million consultations and supporting over 100k consultations every week.
“Noteless is fixing one of many largest inefficiencies in healthcare via AI-driven know-how,” mentioned Lucas Paul, Funding Director at Redstone. “The corporate’s revolutionary method and fast adoption present it’s well-positioned to redefine scientific documentation throughout Europe.”
Noteless believes that medical documentation has lengthy been a supply of frustration for clinicians, consuming hours that might in any other case be spent with sufferers or on skilled growth.
Noteless addresses this problem, providing an AI-powered scribe that robotically generates correct medical notes in actual time throughout consultations.
Its paying buyer base has grown by greater than 360% because the starting of this yr, now serving round 3,000 clinicians throughout Norway, Denmark, and new markets together with the UK, Germany, and the Netherlands.
The platform can be gaining traction past common observe. Specialist docs, physiotherapists, and psychologists are additionally reportedly adopting Noteless.
